Hims & Hers Health tumbles on Q1 revenue miss and GLP-1 margin squeeze

ReutersMay 12, 2026 8:20 AM

View all comments（0）



Shares of telehealth firm Hims & Hers Health HIMS.N slump 16.09% to $24.45 premarket

Co missed Q1 revenue forecasts and posted an unexpected loss, as its move into branded GLP-1 weight-loss drugs squeezed margins and hurt U.S. sales

J.P. Morgan trims PT to $33 from $35; maintains an "overweight" stance on the stock

Brokerage sees that the shift from compounded to Novo-branded GLP-1s was going to create noise in the near-term financials

Adds, that this lends weight to concerns that the shift to branded products could weigh on co's margin profile

Co reported a Q1 loss of 40 cents per share, compared with analysts' estimate for a profit of 4 cents per share

The average rating of 17 analysts covering the stock is "hold" and the median price target is $25 - data compiled by LSEG

As of last day's close, stock down 10.25% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Japan and South Korea Stocks Rise in Early Trade, Samsung Rebounds Over 3%, Trump Arrives in Beijing With Tech Giants

TradingKey - Asian stock markets generally trended higher in Thursday morning trading. The Nikkei 225 opened 0.14% higher, with intraday gains expanding to 200 points at one stage, while SoftBank Group tracked the advance with a gain of over 1%. South Korea’s KOSPI opened 0.4% higher and rallied quickly, with intraday gains reaching 1% and surpassing the 7,900-point mark. LG Electronics led the index constituents, rising more than 5%.

Today’s Market Recap: Tech-Led Rally Drives Record Highs as Trump Arrives in Beijing

Tech-driven gains pushed the S&P 500 and Nasdaq to record highs as President Trump arrived in Beijing alongside Nvidia's CEO. Despite surging PPI data fueling rate-hike fears, strong AI-related growth from Cisco and Alibaba, plus Cerebras Systems' massive IPO demand, sustained investor optimism acro

Anthropic in Talks for Massive $30 Billion Funding, Valuation May Join Trillion-Dollar Ranks

TradingKey - On May 12, Eastern Time, Bloomberg reported that AI startup Anthropic is in preliminary discussions with investors to raise at least $30 billion in new capital at a pre-money valuation exceeding $900 billion. If the deal is finalized, it would mark the company's largest funding round to

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

TradingKey - Cerebras Systems (CBRS) IPO prices May 13–14 at $125–$135/share. $26–$27B valuation, 20x oversubscribed, $510M revenue, 47% net margin, OpenAI 750MW deal. Everything you need to know.

AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

TradingKey - On May 5 (ET), Advanced Micro Devices (AMD) released its first-quarter fiscal 2026 financial results after the market close. The company reported revenue of $10.253 billion, up 38% year-over-year, exceeding market expectations of $9.89 billion. Non-GAAP earnings per share (EPS) were $1.

Featured Tools